semaglutide shortage update An Ongoing Crisis: Raises Dual Concerns for Obesity and Diabetes Treatment FDA Proposes Ban on Bulk
Description
If you cannot tolerate the side effects of semaglutide, or the medication is unavailable, or you have cost and insurance concerns, you can consider alternatives after consulting with your doctor
Regulatory Environment Notice

It is important to keep in mind that people taking GLP-1 medications may already be at risk of developing SIBO for other reasons

A 2025 RAND report found that nearly 12% of U.S

My Day 1 experience has been uneventful, which is exactly what I expected
Current NICE guidance on the management of obesity does not address retatrutide, as it has no UK marketing authorisation
